These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


925 related items for PubMed ID: 27743577

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Hospital revascularisation capability and quality of care after an acute coronary syndrome in Switzerland.
    Welker J, Auer R, Gencer B, Muller O, Cornuz J, Matter CM, Mach F, Windecker S, Rodondi N, Nanchen D.
    Swiss Med Wkly; 2016; 146():w14275. PubMed ID: 26859223
    [Abstract] [Full Text] [Related]

  • 23. Utilization of evidence-based therapy for the secondary prevention of acute coronary syndromes in Australian practice.
    Vermeer NS, Bajorek BV.
    J Clin Pharm Ther; 2008 Dec; 33(6):591-601. PubMed ID: 19138236
    [Abstract] [Full Text] [Related]

  • 24. Use of secondary prevention drug therapy in patients with acute coronary syndrome after hospital discharge.
    Lee HY, Cooke CE, Robertson TA.
    J Manag Care Pharm; 2008 Apr; 14(3):271-80. PubMed ID: 18439049
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Contemporary Trends of Optimal Evidence-Based Medical Therapy at Discharge for Patients Surviving Acute Myocardial Infarction From the Korea Acute Myocardial Infarction Registry.
    Lee JH, Bae MH, Yang DH, Park HS, Cho Y, Jeong MH, Kim YJ, Kim KS, Hur SH, Seong IW, Cho MC, Kim CJ, Chae SC, Korea Acute Myocardial Infarction Registry Investigators.
    Clin Cardiol; 2015 Jun; 38(6):350-6. PubMed ID: 25962712
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. The UK National Health Service: delivering equitable treatment across the spectrum of coronary disease.
    Hawkins NM, Scholes S, Bajekal M, Love H, O'Flaherty M, Raine R, Capewell S.
    Circ Cardiovasc Qual Outcomes; 2013 Mar 01; 6(2):208-16. PubMed ID: 23481523
    [Abstract] [Full Text] [Related]

  • 33. Use of evidence-based interventions in acute coronary syndrome - Subanalysis of the ACCEPT registry.
    Wang R, Neuenschwander FC, Lima Filho A, Moreira CM, Santos ES, Reis HJ, Romano ER, Mattos LA, Berwanger O, Andrade JP.
    Arq Bras Cardiol; 2014 Apr 01; 102(4):319-26. PubMed ID: 24652052
    [Abstract] [Full Text] [Related]

  • 34. Trends in evidence-based treatment and mortality for ST elevation myocardial infarction in Malaysia from 2006 to 2013: time for real change.
    Venkatason P, Zubairi YZ, Hafidz I, Wan WA, Zuhdi AS.
    Ann Saudi Med; 2016 Apr 01; 36(3):184-9. PubMed ID: 27236389
    [Abstract] [Full Text] [Related]

  • 35. Recent trends in the care of patients with non-ST-segment elevation acute coronary syndromes: insights from the CRUSADE initiative.
    Mehta RH, Roe MT, Chen AY, Lytle BL, Pollack CV, Brindis RG, Smith SC, Harrington RA, Fintel D, Fraulo ES, Califf RM, Gibler WB, Ohman EM, Peterson ED.
    Arch Intern Med; 2006 Oct 09; 166(18):2027-34. PubMed ID: 17030838
    [Abstract] [Full Text] [Related]

  • 36. Trends in Gender Differences in Cardiac Care and Outcome After Acute Myocardial Infarction in Western Sweden: A Report From the Swedish Web System for Enhancement of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART).
    Redfors B, Angerås O, Råmunddal T, Petursson P, Haraldsson I, Dworeck C, Odenstedt J, Ioaness D, Ravn-Fischer A, Wellin P, Sjöland H, Tokgozoglu L, Tygesen H, Frick E, Roupe R, Albertsson P, Omerovic E.
    J Am Heart Assoc; 2015 Jul 14; 4(7):. PubMed ID: 26175358
    [Abstract] [Full Text] [Related]

  • 37. Persistence with secondary prevention medications after acute myocardial infarction: Insights from the TRANSLATE-ACS study.
    Mathews R, Wang TY, Honeycutt E, Henry TD, Zettler M, Chang M, Fonarow GC, Peterson ED, TRANSLATE-ACS Study Investigators.
    Am Heart J; 2015 Jul 14; 170(1):62-9. PubMed ID: 26093865
    [Abstract] [Full Text] [Related]

  • 38. Adherence to ACC/AHA performance measures for myocardial infarction in six Middle-Eastern countries: association with in-hospital mortality and clinical characteristics.
    Longenecker JC, Alfaddagh A, Zubaid M, Rashed W, Ridha M, Alenezi F, Alhamdan R, Akbar M, Bulbanat BY, Al-Suwaidi J.
    Int J Cardiol; 2013 Aug 20; 167(4):1406-11. PubMed ID: 22578736
    [Abstract] [Full Text] [Related]

  • 39. Prevalence and correlates of non-optimal secondary medical prevention in patients with stable coronary artery disease.
    Meurice T, Tricot O, Lemesle G, Deneve M, Lejeune P, Biausque F, Cordier C, Savoye C, Hennebert O, Taghipour K, Sivery B, Pruvost P, Alaoui M, Carpentier L, Segrestin B, Lamblin N, Bauters C.
    Arch Cardiovasc Dis; 2015 Aug 20; 108(6-7):340-6. PubMed ID: 25858539
    [Abstract] [Full Text] [Related]

  • 40. Comparison of characteristics, management practices, and outcomes of patients between the global registry and the gulf registry of acute coronary events.
    Awad HH, Zubaid M, Alsheikh-Ali AA, Al Suwaidi J, Anderson FA, Gore JM, Goldberg RJ.
    Am J Cardiol; 2011 Nov 01; 108(9):1252-8. PubMed ID: 21880292
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 47.